329 related articles for article (PubMed ID: 10623111)
21. PEGging biotech growth.
Jacobs T
Nat Biotechnol; 2006 May; 24(5):506. PubMed ID: 16680127
[No Abstract] [Full Text] [Related]
22. Can personalized drugs pay off?
Stipp D
Fortune; 2002 May; 145(10):168. PubMed ID: 12025349
[No Abstract] [Full Text] [Related]
23. Spreading biotech dollars around Washington.
Senior M
Nat Biotechnol; 2013 Aug; 31(8):673-5. PubMed ID: 23929333
[No Abstract] [Full Text] [Related]
24. Biotech R&D goes further afield.
Lawrence S
Nat Biotechnol; 2006 Sep; 24(9):1052. PubMed ID: 16964201
[No Abstract] [Full Text] [Related]
25. Pfizer-Pharmacia merger bodes ill for biotech?
Fletcher L
Nat Biotechnol; 2002 Sep; 20(9):857-8. PubMed ID: 12205489
[No Abstract] [Full Text] [Related]
26. When a long shot is worth a shot.
Jacobs T; Fischer J
Nat Biotechnol; 2005 Jul; 23(7):805. PubMed ID: 16003361
[No Abstract] [Full Text] [Related]
27. A reprise for collaborative financing in biotech.
Ransom J
Nat Biotechnol; 2006 Aug; 24(8):873-4. PubMed ID: 16900110
[No Abstract] [Full Text] [Related]
28. Biotechs hold their own in shifting industry.
Mitchell P
Nat Biotechnol; 2002 Nov; 20(11):1065-6. PubMed ID: 12410238
[No Abstract] [Full Text] [Related]
29. A biotech wreck. It's an industry full of Ps--promises and potential. Call me when they get to profits.
Kadlec D
Time; 2000 Apr; 155(13):93. PubMed ID: 11009708
[No Abstract] [Full Text] [Related]
30. Biotech's next big blowup?
Stires D
Fortune; 2002 Mar; 145(6):154. PubMed ID: 11913033
[No Abstract] [Full Text] [Related]
31. Biotechnology. Bubble, bubble, toil and trouble.
Boorstin J
Fortune; 2001 Jun; 143(12):48. PubMed ID: 11409107
[No Abstract] [Full Text] [Related]
32. No pain, no gain?
Jacobs T
Nat Biotechnol; 2005 Aug; 23(8):934. PubMed ID: 16082357
[No Abstract] [Full Text] [Related]
33. Great company, bad stock.
Jacobs T
Nat Biotechnol; 2005 Feb; 23(2):173. PubMed ID: 15696142
[No Abstract] [Full Text] [Related]
34. Hidden in plain view.
Jacobs T
Nat Biotechnol; 2003 Jun; 21(6):603. PubMed ID: 12776141
[No Abstract] [Full Text] [Related]
35. Eli Lilly enters venture capital arena.
Fletcher L
Nat Biotechnol; 2001 Nov; 19(11):997-8. PubMed ID: 11689830
[No Abstract] [Full Text] [Related]
36. The number on biotech indexes.
Jacobs T
Nat Biotechnol; 2005 Nov; 23(11):1356. PubMed ID: 16273059
[No Abstract] [Full Text] [Related]
37. Any diamonds in the diagnostic coal?
Jacobs T
Nat Biotechnol; 2006 Aug; 24(8):930. PubMed ID: 16900133
[No Abstract] [Full Text] [Related]
38. IPO floodgates unlikely to open after Ark floatation.
Louët S
Nat Biotechnol; 2004 Apr; 22(4):367-8. PubMed ID: 15060538
[No Abstract] [Full Text] [Related]
39. Biotech's wonder ride.
Rynecki D
Fortune; 2000 Mar; 141(5):435-6. PubMed ID: 10788046
[No Abstract] [Full Text] [Related]
40. Finding new life in health stocks.
Armour LA
Fortune; 1997 Sep; 136(6):289-90, 292, 294. PubMed ID: 10173398
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
